Epax has reinforced its position as a leader in highly concentrated omega-3 with a major upgrade to its facility and the launch of next-level molecular distillation technology. The Norwegian marine lipid specialist was already one of the few companies guaranteeing omega-3 with 90 percent minimum triglyceride content as standard. Now, a $40 million investment in its facility in Aalesund has increased its distillation capacity and further improved its ability to offer premium-quality omega-3 … [Read more...] about Next-level distillation technology creates new opportunities for ultra-concentrated omega-3
Ingredients
Aleph Farms Increases Production Capabilities with VBL Therapeutics Facility Acquisition and ESCO Aster Partnership
Efficient capital deployment in Israel and Singapore designed to support scale-up in key markets Aleph Farms, the first company to grow cultivated steaks directly from non-modified cow cells, today announced that it had acquired a manufacturing facility in Modi’in, Israel, and certain related assets from biotechnology company VBL Therapeutics (Nasdaq: VBLT). In addition, Aleph Farms has signed a Memorandum of Understanding (MOU) with ESCO Aster, a vertically-integrated contract manufacturing … [Read more...] about Aleph Farms Increases Production Capabilities with VBL Therapeutics Facility Acquisition and ESCO Aster Partnership
Kerry and c-LEcta enter agreement to market DENARASE® products
28 February 2023: Kerry, a world leader in taste and nutrition, and c-LEcta, a leading biotechnology company in enzyme engineering and bioprocess development, have announced a new partnership to jointly market DENARASE® products. The DENARASE® product family was launched in 2012 and applied in hundreds of clinical and commercial production processes for gene/cell therapies and vaccines. Combining Kerry and c-LEcta’s expertise in the biopharma and pharmaceutical sectors, the partnership will … [Read more...] about Kerry and c-LEcta enter agreement to market DENARASE® products
